A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17-Hydroxylase/17,20-Lyase Deficiency
A. M. Brooke,
N. F. Taylor,
J. H. Shepherd,
M. E. Gore,
T. Ahmad,
L. Lin,
G. Rumsby,
M. Papari-Zareei,
R. J. Auchus,
J. C. Achermann and
J. P. Monson
Center for Endocrinology (A.M.B., J.P.M.), William Harvey Research Institute, St. Bartholomew’s Hospital, Queen Mary, University of London, London EC1A 7BE, United Kingdom; Department of Clinical Biochemistry (N.F.T.), King’s College Hospital, London SE5 9RS, United Kingdom; Department of Medical Oncology (J.H.S., M.E.G., T.A.), Royal Marsden Hospital, London SW3 6JJ, United Kingdom; Institute of Child Health and Department of Medicine (L.L., J.C.A.), and Department of Clinical Biochemistry (G.R.), University College Hospital, London NW1 2BU, United Kingdom; and Division of Endocrinology (M.P.-Z., R.J.A.), Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8857
Address all correspondence and requests for reprints to: Dr. J. P. Monson, Center for Endocrinology, William Harvey Research Institute, St. Bartholomew’s Hospital, Queen Mary, University of London, London EC1A 7BE, United Kingdom. E-mail: j.p.monson{at}qmul.ac.uk.
Context: Combined 17-hydroxylase/17,20-lyase deficiency is arare cause of congenital adrenal hyperplasia and hypogonadism.Novel single amino acid changes in P450c17 provide potentiallyimportant insights into key structural domains for enzyme function.
Objective, Design, and Setting: We report a novel missense mutationin P450c17 in a 17-yr-old female presenting with a malignantmixed germ cell tumor with yolk sac elements who demonstratedclinical and biochemical features of combined 17-hydroxylase/17,20-lyasedeficiency.
Methods: Quantitative urinary steroid analysis was performedby high resolution gas chromatography. All eight coding exonsof CYP17 were PCR amplified and sequenced. The position of arginineat codon 96 was modeled using the CYP17 structure 2c17 (www.rcsb.org).The CYP17 genes were subcloned into pcDNA3, expressed in HEK-293cells, and chromatographed.
Patient and Results: 17-Hydroxylase deficiency was confirmedby marked reductions in urinary and serum cortisol, androgens,and estradiol. Mutational analysis revealed a novel homozygousR96Q missense mutation in P450c17, affecting an amino acid ina key substrate-binding region of the enzyme, leading to completeinactivity.
Conclusion: The description of a second missense mutation atcodon 96 (R96W and R96Q) in the substrate-binding region ofP450c17 provides strong evidence for the key role of this aminoacid in 17-hydroxylase/17,20-lyase function. An associationbetween a malignant germ cell tumor and 17-hydroxylase deficiencyhas not been reported previously, although the presence of gonadoblastomain the ovary of a patient with this condition has recently beendescribed.
This article has been cited by other articles:
V. Dhir, N. Reisch, C. M. Bleicken, J. Lebl, C. Kamrath, H.-P. Schwarz, J. Grotzinger, W. G. Sippell, F. G. Riepe, W. Arlt, et al. Steroid 17{alpha}-Hydroxylase Deficiency: Functional Characterization of Four Mutations (A174E, V178D, R440C, L465P) in the CYP17A1 Gene
J. Clin. Endocrinol. Metab.,
August 1, 2009;
94(8):
3058 - 3064.
[Abstract][Full Text][PDF]
T. Sahakitrungruang, M. K. Tee, P. W. Speiser, and W. L. Miller Novel P450c17 Mutation H373D Causing Combined 17{alpha}-Hydroxylase/17,20-Lyase Deficiency
J. Clin. Endocrinol. Metab.,
August 1, 2009;
94(8):
3089 - 3092.
[Abstract][Full Text][PDF]
-Hydroxylase/17,20-Lyase Deficiency
-hydroxylase/17,20-lyase deficiency is a rare cause of congenital adrenal hyperplasia and hypogonadism. Novel single amino acid changes in P450c17 provide potentially important insights into key structural domains for enzyme function. 
